Answers are grounded in this paper and cite their sources.
We conclude that steroid accumulation in the plasma membrane is the route by which it accesses a binding site on the NMDA receptor. Thus, our results provide a possible structural framework for pharmacologically targeting the transmembrane domains of the receptor.
No takes yet. Share an insight, caveat, or question.
Borovská et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: